Chun-Rui Li (C-R Li, Chunrui Li)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Traumatic Brain Injury

Multiple Myeloma

Top Venues

Science immunology

Blood cancer journal

Clinical and translational medicine

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Chuan Qin, Min Zhang, Da-Peng Mou, Luo-Qi Zhou, Ming-Hao Dong, Liang Huang, Wen Wang, Song-Bai Cai, Yun-Fan You, Ke Shang, Jun Xiao, Di Wang, Chun-Rui Li, Yi Hao, Michael Heming, Long Jun Wu, Gerd Meyer Zu Hörste, Chen Dong, Bi-Tao Bu, Dai-Shi Tian, Wei Wang
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity. Science immunology 9 (95) (2024)
Chuan Qin, Min Zhang, Da-Peng Mou, Luo-Qi Zhou, Ming-Hao Dong, Liang Huang, Wen Wang, Song-Bai Cai, Yun-Fan You, Ke Shang, Jun Xiao, Di Wang, Chun-Rui Li, Yi Hao, Michael Heming, Long Jun Wu, Gerd Meyer Zu Hörste, Chen Dong, Bi-Tao Bu, Dai-Shi Tian, Wei Wang
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity. Science immunology 9 (95) (2024)
Chuan Qin, Min Zhang, Da-Peng Mou, Luo-Qi Zhou, Ming-Hao Dong, Liang Huang, Wen Wang, Song-Bai Cai, Yun-Fan You, Ke Shang, Jun Xiao, Di Wang, Chun-Rui Li, Yi Hao, Michael Heming, Long Jun Wu, Gerd Meyer Zu Hörste, Chen Dong, Bi-Tao Bu, Dai-Shi Tian, Wei Wang
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity. Science immunology 9 (95) (2024)
Di Wang, Haiying Fu, Yimei Que, Haitao Ruan, Menglei Xu, Xiaolu Long, Qiuxia Yu, Chunhui Li, Zhe Li, Songbai Cai, Wei Chen, Cong Sun, Guang Hu, Shuai Wang, Donggou He, Jianming Mei, Wen Wang, Chun-Rui Li
A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma. Journal of translational medicine 21 (1) (2023)
Li-Li Gao, Li Yang, Liang Huang, Yi Xiao, Jinniu Deng, Miao Zheng, Hui Luo, Lijun Jiang, Min Xiao, Chun-Rui Li, Jianfeng Zhou
Clinical and genetic features of Epstein-Barr virus-triggered late-onset primary hemophagocytic lymphohistiocytosis: Ten pedigrees study. Clinical and translational medicine 11 (6) (2022)
Chun-Rui Li, Wenyue Cao, Yimei Que, Qiuxiang Wang, Yi Xiao, Chaojiang Gu, Di Wang, Jue Wang, Lijun Jiang, Hao Xu, Jinhuan Xu, Xiaoxi Zhou, Zhenya Hong, Na Wang, Liang Huang, Shangkun Zhang, Liting Chen, Xia Mao, Min Xiao, Wei Zhang, Li Meng, Yang Cao, Tongcun Zhang, Jian Li, Jianfeng Zhou
A phase I study of anti-BCMA CAR T cell therapy in relapsed/refractory multiple myeloma and plasma cell leukemia. Clinical and translational medicine 11 (3) (2022)
Dan Li, Yimei Que, Shengnan Ding, Guang Hu, Wen Wang, Xia Mao, Ying Wang, Chun-Rui Li, Liang Huang, Jianfeng Zhou, Wei Zhang, Min Xiao
Anti-BCMA CAR-T cells therapy for a patient with extremely high membrane BCMA expression: a case report. Journal for immunotherapy of cancer 10 (9) (2022)
Di Wang, Xia Mao, Yimei Que, Menglei Xu, Yuhang Cheng, Liang Huang, Jue Wang, Yi Xiao, Wen Wang, Guang Hu, Shangkun Zhang, Tongcun Zhang, Chun-Rui Li, Jian-Feng Zhou
Viral infection/reactivation during long-term follow-up in multiple myeloma patients with anti-BCMA CAR therapy. Blood cancer journal 11 (10) (2021)
Di Wang, Jue Wang, Guang Hu, Wen Wang, Yi Xiao, Haodong Cai, Lijun Jiang, Li Meng, Yongkun Yang, Xiaoxi Zhou, Zhenya Hong, Zheng Yao, Min Xiao, Liting Chen, Xia Mao, Li Zhu, Jin Wang, Lugui Qiu, Chun-Rui Li, Jian-Feng Zhou
A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma. Blood 137 (21) (2021)
D Wang, C Zeng, B Xu, J-H Xu, J Wang, L-J Jiang, Q-X Wang, Chun-Rui Li, N Wang, Liang Huang, Y-C Zhang, Y Xiao, J-F Zhou
Anti-CD30 chimeric antigen receptor T cell therapy for relapsed/refractory CD30+ lymphoma patients. Blood cancer journal 10 (1) (2020)